Details of the Drug
General Information of Drug (ID: DM46VT2)
Drug Name |
7-(trifluoromethyl)-1H-indole-2,3-dione
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
391-12-8; 7-Trifluoromethylisatin; 7-(Trifluoromethyl)isatin; 7-(Trifluoromethyl)indoline-2,3-dione; 7-(Trifluoromethyl)-1H-indole-2,3-dione; 7-trifluoromethyl-1h-indole-2,3-dione; 7-(trifluoromethyl)-2,3-dihydro-1h-indole-2,3-dione; MXLDJTXXAYVWDF-UHFFFAOYSA-N; 1H-INDOLE-2,3-DIONE, 7-(TRIFLUOROMETHYL)-; 7-(trifluoromethyl)-1~{H}-indole-2,3-dione; 7-Trifluoroisatin; PubChem9557; AC1LCPWB; ACMC-1CLGD; 7-trifluoromethyl-isatin; Isatin-based compound, 45; AC1Q4IR6; KSC493C7F; SCHEMBL594546; CHEMBL376435; Jsp006801; CTK3J3172
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 215.13 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 1.6 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 0 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 5 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||